These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2109453)

  • 1. Iron overload in untransfused patients with hemoglobin H disease.
    Lin CK; Peng HW; Ho CH; Yung CH
    Acta Haematol; 1990; 83(3):137-9. PubMed ID: 2109453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin H disease complicated iron overload and HLA expression in Chinese.
    Chow MP; Hsu HC; Yung CH; Chau WK; Peng HW; Tsay SH; Tse E; Lin CK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Aug; 23(3):248-52. PubMed ID: 2091905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of HLA class I alleles and haplotypes in Korean.
    Kim TG; Han H; Lim BU; Kim W; Kim SM
    J Korean Med Sci; 1993 Jun; 8(3):180-6. PubMed ID: 8240747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
    Musallam KM; Cappellini MD; Wood JC; Taher AT
    Blood Rev; 2012 Apr; 26 Suppl 1():S16-9. PubMed ID: 22631036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload in Chinese patients with hemoglobin H disease.
    Hsu HC; Lin CK; Tsay SH; Tse E; Ho CH; Chow MP; Yung CH; Peng HW
    Am J Hematol; 1990 Aug; 34(4):287-90. PubMed ID: 2368695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ; Kartikasari AE; Georgiou NA
    Hemoglobin; 2008; 32(1-2):123-34. PubMed ID: 18274990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iron absorption in HbH disease].
    Lin CK; Lin JS; Chen SY; Lo JG; Chien CC; Liu RS; Jiang MC; Lee SH
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):76-80. PubMed ID: 1315200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects.
    Ferro E; Visalli G; Civa R; La Rosa MA; Randazzo Papa G; Baluce B; D'Ascola DG; Piraino B; Salpietro C; Di Pietro A
    Free Radic Biol Med; 2012 Nov; 53(10):1829-37. PubMed ID: 22995637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue iron deposition in untransfused beta-thalassemic mice.
    Garrick LM; Strano-Paul LA; Hoke JE; Kirdani-Ryan LA; Alberico RA; Everett MM; Bannerman RM; Garrick MD
    Exp Hematol; 1989 Jun; 17(5):423-8. PubMed ID: 2714422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin H disease--ten years' experience.
    Hsu HC; Wang CC; Peng HW; Ho CH; Lin CK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jan; 45(1):34-8. PubMed ID: 2168237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic liver disease in transfusion-dependent thalassemia: liver iron quantitation and distribution.
    De Virgiliis S; Cornacchia G; Sanna G; Argiolu F; Galanello R; Fiorelli G; Rais M; Cossu P; Bertolino F; Cao A
    Acta Haematol; 1981; 65(1):32-9. PubMed ID: 6791435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Sánchez-Anzaldo J; Ruiz-Delgado GJ; Jiménez-González C; Carrera B
    Rev Invest Clin; 2001; 53(2):117-20. PubMed ID: 11421105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
    Adekile AD; Azab AF; Al-Sharida SI; Al-Nafisi BA; Akbulut N; Marouf RA; Mustafa NY
    Hemoglobin; 2015; 39(5):320-6. PubMed ID: 26076396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron metabolism in thalassemia intermedia.
    Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
    Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.
    Taher A; Hershko C; Cappellini MD
    Br J Haematol; 2009 Dec; 147(5):634-40. PubMed ID: 19681884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.